Literature DB >> 18199119

Microtubule-associated STOP protein deletion triggers restricted changes in dopaminergic neurotransmission.

Caroline Bouvrais-Veret1, Stéphanie Weiss, Naima Hanoun, Annie Andrieux, Annie Schweitzer, Didier Job, Michel Hamon, Bruno Giros, Marie-Pascale Martres.   

Abstract

The microtubule-associated stable tubule only polypeptide (STOP) protein plays a key-role in neuron architecture and synaptic plasticity. Recent studies suggest that schizophrenia is associated with alterations in the synaptic connectivity. Mice invalidated for the STOP gene display phenotype reminiscent of some schizophrenic-like symptoms, such as behavioral disturbances, dopamine (DA) hyper-reactivity, and possible hypoglutamatergia, partly improved by antipsychotic treatment. In the present work, we examined potential alterations in some DAergic key proteins and behaviors in STOP knockout mice. Whereas the densities of the DA transporter, the vesicular monoamine transporter and the D(1) receptor were not modified, the densities of the D(2) and D(3) receptors were decreased in some DAergic regions in mutant versus wild-type mice. Endogenous DA levels were selectively decreased in DAergic terminals areas, although the in vivo DA synthesis was diminished both in cell bodies and terminal areas. The DA uptake was decreased in accumbic synaptosomes, but not significantly altered in striatal synaptosomes. Finally, STOP knockout mice were hypersensitive to acute and subchronic locomotor effects of cocaine, although the drug equally inhibited DA uptake in mutant and wild-type mice. Altogether, these data showed that deletion of the ubiquitous STOP protein elicited restricted alterations in DAergic neurotransmission, preferentially in the meso-limbic pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18199119     DOI: 10.1111/j.1471-4159.2007.05025.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Nitric oxide synthase mediates the ability of darbepoetin alpha to improve the cognitive performance of STOP null mice.

Authors:  Kosuke Kajitani; Michael Thorne; Michel Samson; George S Robertson
Journal:  Neuropsychopharmacology       Date:  2010-03-24       Impact factor: 7.853

2.  Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.

Authors:  Bryan A Killinger; Anna Moszczynska
Journal:  J Neurochem       Date:  2015-12-10       Impact factor: 5.372

Review 3.  ReMAPping the microtubule landscape: How phosphorylation dictates the activities of microtubule-associated proteins.

Authors:  Amrita Ramkumar; Brigette Y Jong; Kassandra M Ori-McKenney
Journal:  Dev Dyn       Date:  2017-10-27       Impact factor: 3.780

4.  New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia.

Authors:  Avia Merenlender-Wagner; Zeev Shemer; Olga Touloumi; Roza Lagoudaki; Eliezer Giladi; Annie Andrieux; Nikolaos C Grigoriadis; Illana Gozes
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

5.  Altered circadian activity and sleep/wake rhythms in the stable tubule only polypeptide (STOP) null mouse model of schizophrenia.

Authors:  Samuel Deurveilher; Kristin Robin Ko; Brock St C Saumure; George S Robertson; Benjamin Rusak; Kazue Semba
Journal:  Sleep       Date:  2021-04-09       Impact factor: 5.849

6.  Loss of STOP protein impairs peripheral olfactory neurogenesis.

Authors:  Karelle Benardais; Basem Kasem; Alice Couegnas; Brigitte Samama; Sebastien Fernandez; Christiane Schaeffer; Maria-Cristina Antal; Didier Job; Annie Schweitzer; Annie Andrieux; Anne Giersch; Astrid Nehlig; Nelly Boehm
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

7.  Microtubule-associated protein 6 mediates neuronal connectivity through Semaphorin 3E-dependent signalling for axonal growth.

Authors:  Jean-Christophe Deloulme; Sylvie Gory-Fauré; Franck Mauconduit; Sophie Chauvet; Julie Jonckheere; Benoit Boulan; Erik Mire; Jing Xue; Marion Jany; Caroline Maucler; Agathe A Deparis; Olivier Montigon; Alexia Daoust; Emmanuel L Barbier; Christophe Bosc; Nicole Deglon; Jacques Brocard; Eric Denarier; Isabelle Le Brun; Karin Pernet-Gallay; Isabelle Vilgrain; Phillip J Robinson; Hana Lahrech; Fanny Mann; Annie Andrieux
Journal:  Nat Commun       Date:  2015-06-03       Impact factor: 14.919

8.  Reduced expression of STOP/MAP6 in mice leads to cognitive deficits.

Authors:  Julien Volle; Jacques Brocard; Mohamed Saoud; Sylvie Gory-Faure; Jérôme Brunelin; Annie Andrieux; Marie-Françoise Suaud-Chagny
Journal:  Schizophr Bull       Date:  2012-09-20       Impact factor: 9.306

9.  Functional Dysregulations in CA1 Hippocampal Networks of a 3-Hit Mouse Model of Schizophrenia.

Authors:  Solenn Percelay; Jean-Marie Billard; Thomas Freret; Annie Andrieux; Michel Boulouard; Valentine Bouet
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.